Publications of Mathias V. Schmidt

Dedic, N.; Kühne, C.; Jakovcevski, M.; Hartmann, J.; Genewsky, A. J.; Gomes, K. S.; Anderzhanova, E.; Pöhlmann, M. L.; Chang, S.; Kolarz, A. et al.; Vogl, A. M.; Dine, J.; Metzger, M. W.; Schmid, B.; Almada, R. C.; Ressler, K. J.; Wotjak, C. T.; Grinevich, V.; Chen, A.; Schmidt, M. V.; Wurst, W.; Refojo, D.; Deussing, J. M.: Chronic CRH depletion from GABAergic, long-range projection neurons in the extended amygdala reduces dopamine release and increases anxiety. NATURE NEUROSCIENCE 21 (6), pp. 803 - 807 (2018)

Engel, M.; Eggert, C.; Kaplick, P. M.; Eder, M.; Röh, S.; Tietze, L.; Namendorf, C.; Arloth, J.; Weber, P.; Rex-Haffner, M. et al.; Geula, S.; Jakovcevski, M.; Hanna, J. H.; Leshkowitz, D.; Uhr, M.; Wotjak, C. T.; Schmidt, M. V.; Deussing, J. M.; Binder, E. B.; Chen, A.: The Role of m⁶A/m-RNA Methylation in Stress Response Regulation. NEURON 99 (2), pp. 389 - 403 (2018)

Gassen, N. C.; Hartmann, J.; Zannas, A. S.; Kretzschmar, A.; Zschocke, J.; Maccarrone, G.; Hafner, K.; Zellner, A.; Kollmannsberger, L. K.; Wag, K. V. et al.; Mehta, D.; Kloiber, S.; Turck, C. W.; Lucae, S.; Chrousos, G. P.; Holsboer, F.; Binder, E. B.; Ising, M.; Schmidt, M. V.; Rein, T.: FKBP51 inhibits GSK3 beta and augments the effects of distinct psychotropic medications. MOLECULAR PSYCHIATRY 21 (2), pp. 277 - 289 (2016)

Schmidt, M. V.: Stress-Hyporesponsive Period. In: STRESS: PHYSIOLOGY, BIOCHEMISTRY, AND PATHOLOGY, pp. 49 - 56 (2019)

Schmidt, M. V.: The impact of the early life environment on stress resilience in adulthood. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, p. S28 - S28. (2019)

Hartmann, J.; Schmidt, M. V.: Stress resilience as a consequence of early-life adversity, STRESS RESILIENCE: MOLECULAR AND BEHAVIORAL ASPECTS, pp. 149 - 164 (2020)

Buffa, V.; Knaup, F. H.; Heymann, T.; Springer, M.; Schmidt, M. V.; Hausch, F.: Analysis of the Selective Antagonist SAFit2 as a Chemical Probe for the FK506-Binding Protein 51. ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2023)

Yang, H.; Narayan, S.; Schmidt, M. V.: From ligands to behavioral outcomes: understanding the role of mineralocorticoid receptors in brain function. STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS 26 (1), 2204366 (2023)

von Mucke-Heim, I.-A.; Urbina-Trevino, L.; Bordes, J.; Ries, C.; Schmidt, M. V.; Deussing, J. M.: Introducing a depression-like syndrome for translational neuropsychiatry: a plea for taxonomical validity and improved comparability between humans and mice. MOLECULAR PSYCHIATRY (2022)

Manchia, M.; Gathier, A. W.; Yapici-Eser, H.; Schmidt, M. V.; de Quervain, D.; van Amelsvoort, T.; Bisson I, J.; Cryan, J. F.; Howes, O. D.; Pinto, L. et al.; Van der Wee, N. J.; Domschke, K.; Branchi, I.; Vinkers, C. H.: The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across waves. EUROPEAN NEUROPSYCHOPHARMACOLOGY 55, pp. 22 - 83 (2022)

Häusl, A. S.; Balsevich, G.; Gassen, N. C.; Schmidt, M. V.: Focus on FKBP51: A molecular link between stress and metabolic disorders. MOLECULAR METABOLISM 29, pp. 170 - 181 (2019)

Schmidt, M. V.: Linking neuropsychiatric disease to neuronal metabolism. NATURE METABOLISM (2023)

Schmidt, M. V.: The tricky business of predicting the future: How brain and body adapt to early life adversity. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS 155, 105466 (2023)

Bajaj, T.; Haeusl, A. S.; Schmidt, M. V.; Gassen, N. C.: FKBP5/FKBP51 on weight watch: central FKBP5 links regulatory WIPI protein networks to autophagy and metabolic control. AUTOPHAGY (2022)

Schmidt, M. V.: Behavioral neuroscience for the next decade: Progress in complex behavioral analysis. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS 140, 104781 (2022)